CTLA4 and neoplasm: The excellent tumor-killing effect of ICG-PDT in vitro provided us with inspiration to carry out a series of in vivo studies on mice with subcutaneous transplanted MC38 or CT26 cells to investigate the anti-tumor effect of ICG-PDT and the potential combination with CTLA4 antibody.